Edwards Lifesciences Corp (EW)
89.80
+0.66
(+0.74%)
USD |
NYSE |
May 20, 16:00
89.80
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Market Cap: 54.11B for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 53.72B |
| May 16, 2024 | 54.30B |
| May 15, 2024 | 54.33B |
| May 14, 2024 | 52.10B |
| May 13, 2024 | 51.04B |
| May 10, 2024 | 52.26B |
| May 09, 2024 | 52.68B |
| May 08, 2024 | 51.28B |
| May 07, 2024 | 51.73B |
| May 06, 2024 | 51.28B |
| May 03, 2024 | 51.37B |
| May 02, 2024 | 51.26B |
| May 01, 2024 | 50.80B |
| April 30, 2024 | 51.02B |
| April 29, 2024 | 51.79B |
| April 26, 2024 | 52.08B |
| April 25, 2024 | 53.03B |
| April 24, 2024 | 53.38B |
| April 23, 2024 | 52.86B |
| April 22, 2024 | 52.38B |
| April 19, 2024 | 51.77B |
| April 18, 2024 | 52.08B |
| April 17, 2024 | 52.55B |
| April 16, 2024 | 54.25B |
| April 15, 2024 | 53.73B |
| Date | Value |
|---|---|
| April 12, 2024 | 54.38B |
| April 11, 2024 | 55.07B |
| April 10, 2024 | 55.13B |
| April 09, 2024 | 56.05B |
| April 08, 2024 | 55.63B |
| April 05, 2024 | 55.84B |
| April 04, 2024 | 54.94B |
| April 03, 2024 | 56.04B |
| April 02, 2024 | 56.81B |
| April 01, 2024 | 56.78B |
| March 28, 2024 | 57.52B |
| March 27, 2024 | 57.27B |
| March 26, 2024 | 56.23B |
| March 25, 2024 | 56.08B |
| March 22, 2024 | 56.45B |
| March 21, 2024 | 56.99B |
| March 20, 2024 | 56.00B |
| March 19, 2024 | 56.77B |
| March 18, 2024 | 55.89B |
| March 15, 2024 | 55.56B |
| March 14, 2024 | 56.20B |
| March 13, 2024 | 55.94B |
| March 12, 2024 | 54.72B |
| March 11, 2024 | 54.67B |
| March 08, 2024 | 55.46B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
32.60B
Minimum
Mar 23 2020
81.59B
Maximum
Dec 30 2021
53.41B
Average
51.21B
Median
Nov 16 2020
Market Cap Benchmarks
| Stryker Corp | 125.60B |
| Align Technology Inc | 20.13B |
| Abbott Laboratories | 179.62B |
| Boston Scientific Corp | 110.80B |
| Steris PLC | 23.01B |
Market Cap Related Metrics
| PE Ratio | 38.71 |
| PS Ratio | 8.883 |
| Price to Book Value | 7.602 |
| Price to Free Cash Flow | 217.25 |
| Price | 89.80 |
| Earnings Yield | 2.58% |
| Operating PE Ratio | 31.46 |
| Normalized PE Ratio | 34.60 |